
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
Authors' Affiliations: 1 Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland and 2 Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, Maryland
Requests for reprints: Young S. Kim, Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Room 3156, Bethesda, MD 20892. Phone: 301-496-0126; Fax: 301-480-3925; E-mail: yk47s{at}nih.gov.
Various dietary components may modify chronic inflammatory processes at the stage of cytokine production, amplification of nuclear factor-
B–mediated inflammatory gene expression, and the release of anti-inflammatory cytokine, transforming growth factor-β. This review provides a synopsis of the strengths and weaknesses of the evidence that specific bioactive food components influence inflammation-related targets linked to cancer. A target repeatedly surfacing as a site of action for several dietary components is transforming growth factor β. Whereas the use of dietary intervention strategies offers intriguing possibilities for maintaining normal cell function by modifying a process that is essential for cancer development and progression, more information is needed to characterize the minimum quantity of the bioactive food components required to bring about a change in inflammation-mediated cancer, the ideal time for intervention, and the importance of genetics in determining the response. Unquestionably, the societal benefits of using foods and their components to prevent chronic inflammation and associated complications, including cancer, are enormous.
Key Words: Inflammation Cancer Transforming growth factor-β Smads Histone deacetylase inhibitors 15-Hydroxyprostaglandin dehydrogenase Butyrate Diallyl disulfide Sulforaphane Vitamin D Genetics Polymorphisms
This article has been cited by other articles:
![]() |
T. Kozu, G. Iinuma, Y. Ohashi, Y. Saito, T. Akasu, D. Saito, D. B. Alexander, M. Iigo, T. Kakizoe, and H. Tsuda Effect of Orally Administered Bovine Lactoferrin on the Growth of Adenomatous Colorectal Polyps in a Randomized, Placebo-Controlled Clinical Trial Cancer Prevention Research, November 1, 2009; 2(11): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |